NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 44 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,113,099 | +50.3% | 26,765,000 | +28.0% | 0.86% | +53.8% |
| Q2 2023 | $26,686,477 | +0.9% | 20,905,000 | +7.7% | 0.56% | +6.1% |
| Q1 2023 | $26,458,771 | +453.3% | 19,405,000 | +544.3% | 0.53% | +361.4% |
| Q4 2022 | $4,781,837 | +11.5% | 3,012,000 | +0.4% | 0.11% | +16.3% |
| Q3 2022 | $4,287,000 | -92.9% | 3,000,000 | -93.4% | 0.10% | -91.7% |
| Q1 2022 | $60,277,000 | +5.3% | 45,447,000 | 0.0% | 1.18% | -1.8% |
| Q4 2021 | $57,226,000 | -6.4% | 45,447,000 | 0.0% | 1.20% | -14.8% |
| Q3 2021 | $61,127,000 | +1.0% | 45,447,000 | 0.0% | 1.40% | +6.9% |
| Q2 2021 | $60,497,000 | -2.2% | 45,447,000 | 0.0% | 1.31% | -17.6% |
| Q1 2021 | $61,849,000 | +1172.6% | 45,447,000 | +1198.5% | 1.59% | +761.1% |
| Q3 2020 | $4,860,000 | – | 3,500,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |